Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

Shu-Qun Li,1– 3,* Jun-Yi Wu,1,2,* Jia-Yi Wu,1,2,* Huang Xie,4,* Jin-Hai Li,1,2 Zhen-Xin Zeng,1,2 Yang-Kai Fu,1,2 De-Yi Liu,1,2 Han Li,1,2 Wei-Zhao Chen,1,2 Jing-Yao Huang,4 Mao-Lin Yan1,2 1Department of Hepatobiliary Pancreatic Surgery, Shengli Clinical Medical Colleg...

Full description

Bibliographic Details
Main Authors: Li SQ, Wu JY, Xie H, Li JH, Zeng ZX, Fu YK, Liu DY, Li H, Chen WZ, Huang JY, Yan ML
Format: Article
Language:English
Published: Dove Medical Press 2023-10-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
transarterial chemoembolization
lenvatinib
programmed death 1 inhibitor
hepatic cellular carcinoma
main trunk portal vein
triple therapy.
Online Access:https://www.dovepress.com/transarterial-chemoembolization-plus-lenvatinib-and-pd-1-inhibitors-fo-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/transarterial-chemoembolization-plus-lenvatinib-and-pd-1-inhibitors-fo-peer-reviewed-fulltext-article-JHC

Similar Items